• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用心脏T2*磁共振成像和间碘苄胍闪烁显像预测扩张型心肌病患者的不良心脏事件

Prediction of adverse cardiac events in dilated cardiomyopathy using cardiac T2* MRI and MIBG scintigraphy.

作者信息

Nagao Michinobu, Baba Shingo, Yonezawa Masato, Yamasaki Yuzo, Kamitani Takeshi, Isoda Takuro, Kawanami Satoshi, Maruoka Yasuhiro, Kitamura Yoshiyuki, Abe Kohtaro, Higo Taiki, Sunagawa Kenji, Honda Hiroshi

机构信息

Department of Molecular Imaging and Diagnosis, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka City, Fukuoka, 812-8582, Japan,

出版信息

Int J Cardiovasc Imaging. 2015 Feb;31(2):399-407. doi: 10.1007/s10554-014-0562-1. Epub 2014 Oct 28.

DOI:10.1007/s10554-014-0562-1
PMID:25348658
Abstract

Iron deficiency and cardiac sympathetic impairment play a role in the worsening of heart failure, and these two conditions may be linked. The present study aimed to clarify the relationship between myocardial iron deficiency, cardiac sympathetic activity, and major adverse cardiac events (MACE) in patients with dilated cardiomyopathy (DCM). Cardiac T2* MRI for iron deficiency and (123)I-Metaiodobenzylguanidine (MIBG) imaging for cardiac sympathetic activity were performed in 46 patients with DCM. Myocardial T2* value (M-T2*) was calculated by fitting signal intensity data for mid-left ventricular septum to a decay curve using 3-Tesla scanner. (123)I-MIBG washout rate (MIBG-WR) was calculated using a polar-map technique with tomographic data. We analyze the ability of M-T2* and MIBG-WR to predict MACE. MIBG-WR and M-T2* were significantly greater in DCM patients with MACE than in patients without MACE. Receiver-operating-characteristics curve analysis showed that the optimal MIBG-WR and M-T2* thresholds of 35 % and 28.1 ms, and the two combination predict MACE with C-statics of 0.69, 0.73, and 0.82, respectively. Patients with MIBG-WR <35 % and M-T2* <28.1 ms had significantly lower event-free rates than those with MIBG-WR ≥35 % or M-T2* ≥28.1 ms (log-rank value = 4.35, p < 0.05). Cox hazard regression analysis showed that χ(2) and the hazard ratio were 3.99 and 2.15 for development of MACE in patients with MIBG-WR ≥35 % or M-T2* ≥28.1 ms (p < 0.05). Iron deficiency, expressed by a high M-T2*, and MIBG-WR were both independent predictors of MACE in patients with DCM. The two combination was a more powerful predictor of MACE than either parameter alone.

摘要

缺铁和心脏交感神经功能损害在心力衰竭恶化过程中起作用,且这两种情况可能存在关联。本研究旨在阐明扩张型心肌病(DCM)患者中心肌缺铁、心脏交感神经活动与主要不良心脏事件(MACE)之间的关系。对46例DCM患者进行了用于检测缺铁情况的心脏T2磁共振成像(MRI)以及用于检测心脏交感神经活动的(123)I-间碘苄胍(MIBG)显像。使用3特斯拉扫描仪,通过将左心室间隔中部的信号强度数据拟合到衰减曲线来计算心肌T2值(M-T2*)。使用极坐标图技术和断层扫描数据计算(123)I-MIBG洗脱率(MIBG-WR)。我们分析了M-T2和MIBG-WR预测MACE的能力。发生MACE的DCM患者的MIBG-WR和M-T2显著高于未发生MACE的患者。受试者操作特征曲线分析显示,MIBG-WR和M-T2的最佳阈值分别为35%和28.1毫秒,二者联合预测MACE的C统计量分别为0.69、0.73和0.82。MIBG-WR<35%且M-T2<28.1毫秒的患者无事件发生率显著低于MIBG-WR≥35%或M-T2*≥28.1毫秒的患者(对数秩检验值=4.35,p<0.05)。Cox风险回归分析显示,MIBG-WR≥35%或M-T2*≥28.1毫秒的患者发生MACE时的χ2值和风险比分别为3.99和2.15(p<0.05)。高M-T2*所表示的缺铁和MIBG-WR均为DCM患者MACE的独立预测因素。二者联合比单独任何一个参数更能有力地预测MACE。

相似文献

1
Prediction of adverse cardiac events in dilated cardiomyopathy using cardiac T2* MRI and MIBG scintigraphy.利用心脏T2*磁共振成像和间碘苄胍闪烁显像预测扩张型心肌病患者的不良心脏事件
Int J Cardiovasc Imaging. 2015 Feb;31(2):399-407. doi: 10.1007/s10554-014-0562-1. Epub 2014 Oct 28.
2
Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy.心脏磁共振钆延迟增强结合 123I-间碘苄胍闪烁显像术强烈预测扩张型心肌病患者的长期临床转归。
PLoS One. 2019 Jun 20;14(6):e0217865. doi: 10.1371/journal.pone.0217865. eCollection 2019.
3
Prognostic value of myocardial MIBG scintigraphy findings in patients with cardiomyopathy--importance of background correction for quantification of MIBG activity.心肌病患者中心肌间碘苄胍闪烁显像结果的预后价值——心肌间碘苄胍活性定量中本底校正的重要性
Ann Nucl Med. 2002 Sep;16(6):387-93. doi: 10.1007/BF02990076.
4
Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events.扩张型心肌病伴轻中度心力衰竭患者的晚心室电位与心肌 123I-间位碘苄胍闪烁显像的关系:前瞻性猝死事件研究结果。
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1056-64. doi: 10.1007/s00259-012-2092-1. Epub 2012 Mar 14.
5
Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.评估潜在病因和心脏交感神经支配以识别心脏性死亡高危患者。
J Nucl Med. 2001 Dec;42(12):1757-67.
6
Prognostic value of 123I-metaiodobenzylguanidine in patients with various heart diseases.123I-间碘苄胍在各种心脏病患者中的预后价值。
Ann Nucl Med. 2007 Nov;21(9):513-20. doi: 10.1007/s12149-007-0062-7. Epub 2007 Nov 26.
7
Long-term prognostic stratification by a combination of (123)I-metaiodobenzylguanidine scintigraphy and ejection fraction in dilated cardiomyopathy.(123)I-间碘苄胍闪烁显像与射血分数联合对扩张型心肌病的长期预后分层。
Ann Nucl Med. 2011 Jul;25(6):419-24. doi: 10.1007/s12149-011-0479-x. Epub 2011 Apr 2.
8
Cardiac sympathetic activity and relationship to cardiac events and left ventricular reverse remodeling in patients with non-ischemic dilated cardiomyopathy.非缺血性扩张型心肌病患者的心脏交感活性与心脏事件及左心室逆重构的关系。
Ann Nucl Med. 2023 Aug;37(8):451-461. doi: 10.1007/s12149-023-01838-9. Epub 2023 Jun 5.
9
Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy.通过联合肺和心脏碘-123间碘苄胍摄取评估特发性扩张型心肌病患者的风险分层。
Am J Cardiol. 2008 May 15;101(10):1482-6. doi: 10.1016/j.amjcard.2008.01.030. Epub 2008 Mar 26.
10
A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.多中心队列研究的荟萃分析:(123)I-间碘苄胍成像用于评估心力衰竭的长期预后中的交感神经支配。
JACC Cardiovasc Imaging. 2013 Jul;6(7):772-84. doi: 10.1016/j.jcmg.2013.02.007.

引用本文的文献

1
Cardiovascular magnetic resonance native T and T quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.心肌病和心脏移植的心血管磁共振原生T和T定量值:系统评价和荟萃分析。
J Cardiovasc Magn Reson. 2020 May 11;22(1):34. doi: 10.1186/s12968-020-00627-x.
2
Structural and functional abnormalities in iron-depleted heart.缺铁性心脏的结构和功能异常。
Heart Fail Rev. 2019 Mar;24(2):269-277. doi: 10.1007/s10741-018-9738-4.
3
Ventricular Tachycardia (VT) Storm After Cryoballoon-Based Pulmonary Vein Isolation.

本文引用的文献

1
Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions.使用 SPECT 采集的容积量化评估全球心脏 I-123 MIBG 摄取和清除。
J Nucl Cardiol. 2012 Aug;19(4):752-62. doi: 10.1007/s12350-012-9539-4. Epub 2012 Jun 6.
2
Cardiac mortality assessment improved by evaluation of cardiac sympathetic nerve activity in combination with hemoglobin and kidney function in chronic heart failure patients.评估慢性心力衰竭患者心脏自主神经活性结合血红蛋白和肾功能可改善心脏死亡率评估。
J Nucl Med. 2012 May;53(5):731-40. doi: 10.2967/jnumed.111.095786. Epub 2012 Apr 10.
3
基于冷冻球囊的肺静脉隔离术后室性心动过速风暴
Am J Case Rep. 2018 Sep 11;19:1078-1082. doi: 10.12659/AJCR.908999.
4
Iron in kidney and heart failure: from theory to practice.肾脏和心力衰竭中的铁:从理论到实践
Int Urol Nephrol. 2018 Mar;50(3):481-493. doi: 10.1007/s11255-017-1708-6. Epub 2017 Sep 22.
5
Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study.静脉注射铁剂治疗心力衰竭患者左心室射血分数的恢复:一项初步研究。
ESC Heart Fail. 2016 Dec;3(4):293-298. doi: 10.1002/ehf2.12101. Epub 2016 Jul 26.
6
Cardiovascular imaging 2015 in the International Journal of Cardiovascular Imaging.《国际心血管影像杂志》2015年心血管成像专刊
Int J Cardiovasc Imaging. 2016 May;32(5):697-709. doi: 10.1007/s10554-016-0877-1.
7
Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure?缺铁的纠正是否是心力衰竭治疗的新补充?
Int J Mol Sci. 2015 Jun 18;16(6):14056-74. doi: 10.3390/ijms160614056.
Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs.
心脏交感神经支配和心肌灌注受损与致命性心律失常有关:植入 ICD 患者心脏示踪剂的定量分析。
J Nucl Med. 2010 Aug;51(8):1241-9. doi: 10.2967/jnumed.110.074971.
4
International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers.五项地中海贫血中心单屏气 T2*MR 心脏和肝脏铁评估的国际可重复性。
J Magn Reson Imaging. 2010 Aug;32(2):315-9. doi: 10.1002/jmri.22245.
5
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.心肌碘-123 间碘苄胍显像与心力衰竭中的心脏事件。前瞻性 ADMIRE-HF(AdreView 心肌成像用于心力衰竭风险评估)研究的结果。
J Am Coll Cardiol. 2010 May 18;55(20):2212-21. doi: 10.1016/j.jacc.2010.01.014. Epub 2010 Feb 25.
6
Advanced heart failure treated with continuous-flow left ventricular assist device.采用连续血流左心室辅助装置治疗晚期心力衰竭。
N Engl J Med. 2009 Dec 3;361(23):2241-51. doi: 10.1056/NEJMoa0909938. Epub 2009 Nov 17.
7
Anemia and mortality in heart failure patients a systematic review and meta-analysis.心力衰竭患者的贫血与死亡率:一项系统评价和荟萃分析
J Am Coll Cardiol. 2008 Sep 2;52(10):818-27. doi: 10.1016/j.jacc.2008.04.061.
8
Forging a field: the golden age of iron biology.开创一个领域:铁生物学的黄金时代。
Blood. 2008 Jul 15;112(2):219-30. doi: 10.1182/blood-2007-12-077388.
9
Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.窄QRS波群心力衰竭患者的心脏再同步治疗
N Engl J Med. 2007 Dec 13;357(24):2461-71. doi: 10.1056/NEJMoa0706695. Epub 2007 Nov 6.
10
Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.慢性心力衰竭中的贫血:患病率、病因、临床关联及治疗选择。
Circulation. 2006 May 23;113(20):2454-61. doi: 10.1161/CIRCULATIONAHA.105.583666.